Whitehawk Therapeutics (WHWK) Non-cash Items (2015 - 2026)

Whitehawk Therapeutics (WHWK) has 11 years of Non-cash Items data on file, last reported at $8.1 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $8.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (changed N/A YoY), and the FY2025 annual result was $2.6 million, up 45.32% from the prior year.
• Non-cash Items rose to $8.1 million in Q1 2026 per WHWK's latest filing, from $2.6 million in the prior quarter.
• Over five years, Non-cash Items peaked at $8.1 million in Q1 2026 and troughed at $459000.0 in Q2 2025.
• A 4-year average of $3.2 million and a median of $2.2 million in 2024 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items soared 399.91% in 2022, then jumped 45.32% in 2025.
• A 4-year view of Non-cash Items shows it stood at $5.6 million in 2022, then plunged by 67.72% to $1.8 million in 2024, then jumped by 45.32% to $2.6 million in 2025, then jumped by 205.41% to $8.1 million in 2026.
• Business Quant data shows WHWK's Non-cash Items at $8.1 million in Q1 2026, $2.6 million in Q4 2025, and $539000.0 in Q3 2025.